Literature DB >> 19488086

Intravascular lymphomatosis of the brain in a patient with myelodysplastic syndrome.

Gregorius J Sips1, Colum F Amory, Bradley N Delman, George M Kleinman, Lewis R Lipsey, Stanley Tuhrim.   

Abstract

BACKGROUND: A 77-year-old retired research pharmacologist with a long-standing history of anemia and a recent pathologically confirmed diagnosis of myelodysplastic syndrome was referred to a stroke unit for evaluation of slowly progressive cognitive deterioration, confusion and paroxysmal stroke-like episodes. A previous neurological work-up had revealed no noteworthy abnormalities except for chronic bilateral caudate infarctions seen on MRI and CT examinations of the brain. INVESTIGATIONS: Physical examination, laboratory testing, brain MRI scanning, EEG, transesophageal echocardiography, cerebral angiography, CT scanning, and brain biopsy. DIAGNOSIS: Intravascular lymphomatosis of the brain. MANAGEMENT: Combined chemotherapy with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) and rituximab.

Entities:  

Mesh:

Year:  2009        PMID: 19488086     DOI: 10.1038/nrneurol.2009.36

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  26 in total

1.  Insights into leukemogenesis from therapy-related leukemia.

Authors:  Jens Pedersen-Bjergaard
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

Review 2.  A new approach to the diagnosis and treatment of intravascular lymphoma.

Authors:  Joachim M Baehring; Janina Longtine; Fred H Hochberg
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

3.  Risk factors of myelodysplastic syndromes: a case-control study.

Authors:  S S Strom; Y Gu; S K Gruschkus; S A Pierce; E H Estey
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

4.  Intravascular variant of diffuse large B-cell lymphoma with combined endocrine involvement.

Authors:  Marián Svajdler; Ivica Lazúrová; Peter Bohus; Miroslav Pal'ko
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

5.  The neurological masquerade of intravascular lymphomatosis.

Authors:  Xabier Beristain; Biagio Azzarelli
Journal:  Arch Neurol       Date:  2002-03

Review 6.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome.

Authors:  Hesham M Amin; Iman Jilani; Elihu H Estey; Michael J Keating; Amanda L Dey; Taghi Manshouri; Hagop M Kantarjian; Zeev Estrov; Jorge E Cortes; Deborah A Thomas; Francis J Giles; Maher Albitar
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

8.  [Myelodysplastic syndrome with neoplastic angioendotheliosis: report of a case].

Authors:  S Ozaki; Y Kawachi; T Igaki; N Ogasawara; T Uchida; M Mori; S Setsu
Journal:  Rinsho Ketsueki       Date:  1991-11

Review 9.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

Authors:  Andrés J M Ferreri; Elías Campo; John F Seymour; Rein Willemze; Fiorella Ilariucci; Achille Ambrosetti; Emanuele Zucca; Giuseppe Rossi; Armando López-Guillermo; Miguel A Pavlovsky; Marie-Louise Geerts; Anna Candoni; Maurizio Lestani; Silvia Asioli; Mario Milani; Miguel A Piris; Stefano Pileri; Fabio Facchetti; Franco Cavalli; Maurilio Ponzoni
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 10.  Myelodysplastic syndromes: molecular pathogenesis and genomic changes.

Authors:  Florian Nolte; Wolf-K Hofmann
Journal:  Ann Hematol       Date:  2008-05-31       Impact factor: 3.673

View more
  1 in total

1.  Intravascular lymphomatosis and intracerebral haemorrhage.

Authors:  Maria Grazia Passarin; Patrick Y Wen; Emanuela Vattemi; Ebba Buffone; Claudio Ghimenton; Lamberto Bontempini; Sarah Ottaviani; Anna Maria Musso; Rebecca Pedersini
Journal:  Neurol Sci       Date:  2010-06-02       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.